Search results
Opus Genetics has launched an early-stage clinical trial of OPGx-MERTK, an investigational gene therapy for MERTK-related Retinitis Pigmentosa (RP), a condition that causes progressive vision loss due to photoreceptor degeneration.
Wednesday 29 April 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Cindy & Jane for our second meeting with our guest speaker John Darker who will be sharing his love of audiobooks and knowledge around listening to them via Audible.
Jing Yu is a bioinformatician with the Eye Research Group at Oxford University, and is part of the UK Inherited Retinal Dystrophy Consortium (UKIRDC) team, funded by a Retina UK grant.
A huge thank you to everyone who completed our 2025 sight loss survey. This year we received over 600 responses. It follows similar surveys in 2019 and 2022 which led directly to the introduction of our Unlock Genetics and Discover Wellbeing resources, as well as shaping our work with the professional community who support people with inherited sight loss.
Tribute to Retina UK founder Lynda Cantor MBE
Thank you to all those who completed our recent Sight Loss Survey – almost 700 of you took the time to share your experiences.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Tuesday 14 April 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Brian Coates & Steve Cox for our first meeting of 2026 where we are delighted to welcome our guest speakers and avid gardeners, John Huxley & Scott Racine.
